Archive - September 2018
FDA Approves Libtayo (cemiplimab-rwlc) for Advanced Cutaneous Squamous Cell Carcinoma
Bayer to challenge Avastin legal ruling
FDA approval gained, Pfizer sets sights on first-line NSCLC market
Lilly’s Emgality wins first nod for migraine prevention
GW Pharma’s Epidiolex nears US launch
FDA Approves Genentech’s Xolair (omalizumab) Prefilled Syringe Formulation
NHS England pledges £10m to support GP services over winter
US green light for Pfizer’s lung cancer drug